This Article Full Text Full Text (PDF) Supplemental Data Figures All Versions of this Article: 20/3/573    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koyanagi, S. Articles by Ohdo, S. Search for Related Content PubMed PubMed Citation Articles by Koyanagi, S. Articles by Ohdo, S.

Chronic Treatment with Prednisolone Represses the Circadian Oscillation of Clock Gene Expression in Mouse Peripheral Tissues

Department of Biochemistry (S.K., S.O., Y.K., H.S., S.S.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan; Pharmaceutics (K.U., S.O.), Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan; and Division of Molecular Brain Science (H.O.), Department of Brain Sciences, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan

Address all correspondence and requests for reprints to: Shigehiro Ohdo, Ph.D., Professor Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan. E-mail: ohdo{at}phar.kyushu-u.ac.jp.

Although altered homeostatic regulation, including disturbance of 24-h rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 (Per2), Rev-erb, and Bmal1 mRNA in HepG2 cells. Because the attenuation of clock gene oscillations was blocked by pretreating the cells with a Per1 antisense phosphothioate oligodeoxynucleotide, the extensive expression of Per1 induced by PSL may have resulted in the reduced amplitude of other clock gene oscillations. Continuous administration of PSL into mice constitutively increased the Per1 mRNA levels in liver and skeletal muscle, which seems to attenuate the oscillation in the expressions of Per2, Rev-erb, and Bmal1. However, a single daily administration of PSL at the time of day corresponding to acrophase of endogenous glucocorticoid levels had little effect on the rhythmic expression of clock genes. These results suggest a possible pharmacological action by PSL on the core circadian oscillation mechanism and indicate the possibility that the alteration of clock function induced by PSL can be avoided by optimizing the dosing schedule.

NURSA Molecule Pages Link:

Nuclear Receptors:   REV-ERBα  |  GR

This article has been cited by other articles:

				N. Burioka, S. Koyanagi, M. Endo, M. Takata, Y. Fukuoka, M. Miyata, K. Takeda, H. Chikumi, S. Ohdo, and E. Shimizu Clock gene dysfunction in patients with obstructive sleep apnoea syndrome Eur. Respir. J., July 1, 2008; 32(1): 105 - 112. [Abstract] [Full Text] [PDF]

				N. Hayasaka, T. Yaita, T. Kuwaki, S. Honma, K.-i. Honma, T. Kudo, and S. Shibata Optimization of Dosing Schedule of Daily Inhalant Dexamethasone to Minimize Phase Shifting of Clock Gene Expression Rhythm in the Lungs of the Asthma Mouse Model Endocrinology, July 1, 2007; 148(7): 3316 - 3326. [Abstract] [Full Text] [PDF]